Cargando…

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study

BACKGROUND: Standard bleomycin-containing first-line therapy and/or irradiation may cause pulmonary toxicity in Hodgkin lymphoma (HL) patients. Our aim was to prospectively assess effects of chest irradiation, bleomycin administration, and other factors on lung function in the treatment of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jona, Adam, Miltenyi, Zsofia, Pinczes, Laszlo, Kerek, Patricia, Bittner, Nora, Szilasi, Maria, Barna, Sandor, Illes, Arpad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734491/ https://www.ncbi.nlm.nih.gov/pubmed/35059088 http://dx.doi.org/10.14740/jh929

Ejemplares similares

Transition Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma– Our Histopathological and Clinical Experience With Patients With Intermediate Lymphoma
por: Simon, Zsófia, et al.
Publicado: (2021)

Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma
por: Jóna, Ádám, et al.
Publicado: (2016)

Changing Patterns in the Clinical Pathological Features of Hodgkin Lymphoma: A Report from Debrecen, Hungary
por: Miltényi, Zsófia, et al.
Publicado: (2011)

Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma
por: Pinczés, László Imre, et al.
Publicado: (2020)

Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary
por: Husi, Kata, et al.
Publicado: (2023)

Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation
por: Jóna, Ádám, et al.
Publicado: (2016)

Clinical and biological prognostic factors in follicular lymphoma patients
por: Jóna, Ádám, et al.
Publicado: (2022)

Employment status and health related quality of life among Hodgkin-lymphoma survivors’– results based on data from a major treatment center in Hungary
por: Magyari, Ferenc, et al.
Publicado: (2017)

Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary
por: Magyari, Ferenc, et al.
Publicado: (2022)

Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
por: Udvardy, Miklós, et al.
Publicado: (2023)

Late Effect of the Cervical Irradiation on Periodontal Status and Cariogen Flora in Hodgkin Lymphoma Patients
por: Simon, Zsófia, et al.
Publicado: (2011)

A Case of Therapy-related Acute Myeloid Leukemia Following Treatment with 5-Fluorouracil
por: Pinczés, László, et al.
Publicado: (2018)

Quantitative Analysis of Carbonic Anhydrase IX Uncovers Hypoxia-Related Functional Differences in Classical Hodgkin Lymphoma Subtypes
por: Matolay, Orsolya, et al.
Publicado: (2019)

Pulmonary toxicity induced by bleomycin in a patient with Hodgkin lymphoma
por: Oliveira, CF, et al.
Publicado: (2005)

Bleomycin in Hodgkin's Lymphoma – A Boon or a Bane? – A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma
por: Udupa, Chethana Babu K, et al.
Publicado: (2019)

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
por: Magyari, Ferenc, et al.
Publicado: (2022)

Primary Pulmonary Hodgkin Lymphoma
por: Tanveer, Shumaila, et al.
Publicado: (2015)

Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma
por: Sabet, Yasmin, et al.
Publicado: (2016)

Maintaining Efficacy But Decreasing Toxicity in the Treatment of Hodgkin Lymphoma
por: Ansell, Stephen M.
Publicado: (2017)

Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.
por: Yokose, N., et al.
Publicado: (1998)

Efficacies and Toxicities of Seven Chemotherapy Regimens for Advanced Hodgkin Lymphoma
por: Pei, Fajun, et al.
Publicado: (2021)

Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity
por: Barrett, Aisling, et al.
Publicado: (2023)

Pediatric pulmonary hodgkin lymphoma: Analysis of 10 years data from a single center
por: Urasinski, T, et al.
Publicado: (2010)

Immunotherapies in Non-Hodgkin’s Lymphoma
por: Bezombes, Christine, et al.
Publicado: (2021)

Pulmonary Hodgkin Lymphoma in a Patient with Crohn’s Disease
por: Park, Jae-Young, et al.
Publicado: (2014)

Pulmonary Function after Proton Therapy for Hodgkin Lymphoma
por: O'steen, Lillie, et al.
Publicado: (2019)

Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
por: Toltz, Allison, et al.
Publicado: (2015)

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
por: Pepper, Niklas Benedikt, et al.
Publicado: (2020)

Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era
por: Follows, Annabel M., et al.
Publicado: (2022)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

Multiloculated Cavitary Primary Pulmonary Hodgkin Lymphoma: Case Series
por: Aljehani, Yasser, et al.
Publicado: (2018)

What Lies Behind the Cannonball Pulmonary Metastases: Hodgkin's Lymphoma?
por: Ramdani, Hiba, et al.
Publicado: (2022)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

An Atypical Presentation of Non-Hodgkin’s Lymphoma
por: Dias Antunes, Joana, et al.
Publicado: (2022)

MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients
por: Navarro, Alfons, et al.
Publicado: (2013)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8mg34r64amg5l6luhbh75j3m6u